CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 6, November/December 2016
362
AFRICA
Data were obtained using a standard questionnaire,
which collected information on age, gender, education level,
duration of hypertension, the number and class of drugs
taken for hypertension or other conditions, compliance with
antihypertensive drugs, family history of hypertension (FH-HT),
diabetes (FH-DM) or cardiovascular disease (CVD), smoking
and alcohol use, and physical activity.
A physical examination was performed on each patient
to measure height, weight, waist circumference (WC), blood
pressure and pulse rate. Height and weight were measured
with reference to recommended procedures. Body mass index
(BMI) was calculated as weight (kg)/height
2
(m). Overweight
and obesity were defined as BMI
>
25 and
>
30 kg/m².
7
Waist
circumference (WC) was taken to the nearest 1 cm, using a tape
measure. Central obesity was defined as WC
>
94 cm in men and
>
80 cm in women.
8
Seated blood pressure (BP) was measured using an electronic
device, OMRON M3 Intellisense (OMRON Health, Vietnam),
on the left arm at the level of the heart after five minutes’ rest.
BP was measured three times and the mean of the last two
readings was used for analysis. Pulse pressure (PP) was calculated
as systolic (SBP) minus diastolic blood pressure (DBP). Mean
arterial pressure (MAP) was DBP
+
PP divided by 3.
While on their usual diet, a venous blood sample was
taken from an antecubital vein for the determination of levels
of serum uric acid, cholesterol and its sub-fractions, and
triglycerides using enzymatic methods (Biomérieux France).
Low-density lipoprotein cholesterol (LDL-C) was calculated
using the Friedewald formula.
9
For estimated glomerular filtration rate (eGFR)
determinations, the abbreviated equation from the MDRD
study was used.
10
We calibrated the creatinine results measured
using the Jaffe method against a traceable isotope dilution mass
spectrometry (IDMS) enzymatic method (creatinine
+
, Roche
enzymatic diagnostics) as described elsewhere.
11
Recalibrated
serum creatinine values were thereafter computed for each
participant and the new MDRD study equation was used
for estimation of eGFR as 175
×
[serum creatinine level (mg/
dl)] – 1.154
×
[age (years)] – 0.203. For women and for blacks
(all patients in our study), the product of this equation was
multiplied by a correction factor of 0.742 and 1.21, respectively.
All analyses were performed at the National Laboratory of the
National AIDS Control Program.
Capillary blood glucose was determined using Accu-chek
Compact plus glucometer (Roche Diagnostica, Manheim,
Germany) with the glucose oxidase method. Reactive Dipstick
Condor Teco (Condor Teco Medical Technology Co, China)
was used to determine semi-quantitative proteinuria. A resting
electrocardiogram (ECG) was performed for each patient and
the Sokolow index was calculated. The 2007 European Society
of Hypertension/European Society of Cardiology (ESH/ESC)
guidelines
12
were used to evaluate global cardiovascular (CV) risk
in the study population.
Subjects were classified as having: controlled SBP and DBP
if current antihypertensive treatment was accompanied by clinic
SBP
<
140 mmHg and clinic DBP
<
90 mmHg; uncontrolled
SBP only if SBP was
≥
140 mmHg and DBP
<
90 mmHg;
uncontrolled DBP only if DBP was
≥
90 mmHg and SBP
<
140
mmHg; uncontrolled SBP and DBP if SBP and DBP were
≥
140
mmHg and
≥
90 mmHg, respectively.
12
The metabolic syndrome was defined according to
International Diabetes Federation criteria.
8
Diabetes was defined
as blood glucose level
≥
126 mg/dl (6.99 mmol/l) or current use
of antidiabetic drugs.
13
Excessive alcohol intake was defined by regular intake of two
or more glasses per day of beer or equivalent for at least one
year, knowing that one glass of beer contains 10 g of alcohol.
14
Smoking was defined as regular consumption of at least one
cigarette per day for more than five years or having stopped
smoking for less than five years.
15
Physical activity in leisure time was categorised as active
for subjects who exercised for at least four hours per week,
and inactive or sedentary for all the others.
16
Compliance
with therapy was defined as self-reported regular intake of
antihypertensive drugs.
ECG-determined left ventricular hypertrophy (ECG-LVH)
was defined as a Sokolow index
>
35 cm.
17
According to K/DOQI
guidelines,
18
chronic kidney disease (CKD) and renal failure (RF)
were defined as eGFR
<
90 and
<
60 ml/min/1.73 m², respectively.
According to the 2007 ESH/ESC guidelines,
12
moderate, high
and very high absolute CV risk were defined as 10–20, 20–30 and
≥
30% probability of a CV event in the next 10 years, respectively.
Proteinuria was defined as dipstick proteinuria
≥
1
+
.
19
The study was conducted in accordance with the principles of
the 18th World Assembly (Helsinki, 1964). The study protocol
was submitted to the ethics committee of Kinshasa School
of Public Health of the University of Kinshasa and received
clearance under the number ESP/CE/024/2012.
Statistical analysis
Data are expressed as mean
±
standard deviation (SD) or
relative frequency (%). Chi-squared and Student’s
t
-tests
were used to compare categorical and continuous variables,
respectively. Skewed continuous variables were compared using
the non-parametric Mann–Whitney test. Stepwise logistic
regression analysis was used to identify correlates of uncontrolled
hypertension; odds ratio (OR) and confidence interval (CI) were
obtained for each independent variable. To remain in the model a
factor had to reach a
p
-value
≤
0.05. All statistical analyses were
performed with SPSS version 20 for Windows at the Division of
Epidemiology and Biostatistics of Kinshasa School of Public
Health, University of Kinshasa.
Results
A total of 298 hypertensive patients, 208 women and 90 men,
were recruited in this study. Clinical characteristics of the study
population as a whole are given in Table 1. Their mean age was
64
±
10 years; they had on average a BMI of 26
±
5 kg/m², a WC
of 90
±
11 cm, a SBP of 151
±
24 mmHg and a DBP of 87
±
14
mmHg.
A family history of hypertension or diabetes was present in
50 and 31% of patients, respectively. In 67% of patients, the
duration of hypertension was less than 10 years. The majority of
patients (66%) were receiving monotherapy, most with diuretics
(43%) (Table 2). Of the 34% of patients on combined therapy,
a notable proportion (17%) was receiving a fixed combination
of an angiotensin converting enzyme and a thiazide diuretic.
With regard to non-antihypertensive drugs, 29, 9 and 6% of